Pfizer S.W.O.T analysis

About this template

Founded in 1849, Pfizer is an established pharma and healthcare company, based in New York. This Pfizer SWOT analysis template explores the internal and external factors, which may influence the company’s management strategies and decision-making. You can download this template to analyze the company’s future.

Strengths

• Brand value:

Pfizer has been a recognized global pharmaceutical company for 170 years with 70,000 employees. The company has built a strong reputation, which is accredited to quality and innovation.

• Globally recognized:

  Currently, Pfizer enjoys an international presence in over 125 countries. This global market reach gives them high capital growth and massive sales.

• Strong finances:

Pfizer has a strong financial position, considering its global sales and operations. This strength helps the company invest in its research departments and fulfill strategic goals.

• Established products:

Pfizer produces a range of products, including internal medicine, vaccines, oncology, and clinical products. It helps them avoid the financial losses from patent expiration on individual drugs.

Weaknesses

• Expensive drug development:

Pfizer is popular for its costly drug development process against competitors. Moreover, the government and healthcare providers put constant pressure on the company to reduce the prices for affordable healthcare costs. Hence, it can negatively impact Pfizer's business.

• Dependence on the US market:

A company should have established operations worldwide for a higher success rate. However, Pfizer’s revenue is extremely dependent on the US market.

• Law issues:

Currently, Pfizer is subjected to numerous legal issues and litigations, specifically for product liability and intellectual property rights. Eventually, these issues can result in delays in the new product launches and penalties.

• Patent expirations:

Like any other pharmaceutical company, Pfizer faces the challenge of patent expiration on a few established drugs. When their patent expires, competitors launch generic versions of their drugs, which can impact Pfizer’s business significantly.

Opportunities

• Emerging markets:

Developing economies with rising healthcare needs is a big opportunity for Pfizer. The company can access these markets by collaborating with local distribution networks.

• Increasing healthcare needs awareness:

Recently, digital health technology has been the new trend and Pfizer can capitalize on this. The company can invest in the development of patient monitoring and support tools.

• Strategic partnerships:

Pfizer is shifting its focus toward diversifying its product portfolio. For this, the company is venturing into strategic partnerships to strengthen its R&D department.

• Increase demand for healthcare solutions:

The world is getting more health-conscious as it experiences epidemics, pandemics, and other diseases. Here, Pfizer can innovate products in the global market by leveraging its big customer base.

Threats

• Resignation of higher authorities:

It is a big red flag when any company’s higher management authorities leave their positions. A similar situation happened with Pfizer, which is disturbing the company’s reputation in the market.

• Risk of unsuccessful product launches:

Though not a big failure, Pfizer is facing some issues with new product launches, and legal risks are adding to it.

• Economic slowdown:

The world has experienced slow economic activity during the pandemic. It has impacted the inflation rates, manufacturing costs, and labor. A similar event can be a threat to Pfizer in the future.

• Market competition:

As discussed above, the pharmaceutical industry is filled with competition with new products entering the market. Hence, the affordable products in the market are a challenge for Pfizer.